Oncotelic Therapeutics, Inc. (OTLC)

Oncotelic Therapeutics Revenue

Oncotelic Therapeutics had revenue of $250.00K in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $250.00K. That makes Oncotelic Therapeutics the 45,231st largest company in the world by revenue and 6,554th in the United States.

• Revenue (ttm): 250.00K
• Revenue Growth: n/a
• P/S Ratio: 34.73
• Revenue / Employee: 6.10K
• Employees: 43
• Market Cap: 8.68M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	70.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error